Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Herpesviridae, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them? | Viruses | 2024 | 38257833 | PubTator, text mining | PubMed |
| PDLIM7 Promotes Tumor Metastasis in Papillary Thyroid Carcinoma via Stabilizing Focal Adhesion Kinase Protein. | Thyroid | 2024 | 38243825 | PubTator, text mining | PubMed |
| Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. | Mol Cancer | 2024 | 38243280 | PubTator, text mining | PubMed |
| Anti-SARS-CoV-2-specific antibodies in human breast milk following SARS-CoV-2 infection during pregnancy: a prospective cohort study. | Int Breastfeed J | 2024 | 38238855 | PubTator, text mining | PubMed |
| CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy. | Cancer Lett | 2024 | 38211650 | PubTator, text mining | PubMed |
| Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex. | Nat Commun | 2024 | 38195569 | PubTator, text mining | PubMed |
| Detection of Epstein-Barr virus infection in primary junctional epithelial cell cultures. | J Oral Microbiol | 2024 | 38188074 | PubTator, text mining | PubMed |
| A higher number of exhausted local PD1+, but not TIM3+, NK cells in advanced endometriosis. | Heliyon | 2024 | 38173487 | PubTator, text mining | PubMed |
| RNA m6A methylation regulators in liver cancer. | Cancer Cell Int | 2024 | 38166832 | PubTator, text mining | PubMed |
| Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. | Blood Adv | 2024 | 38163318 | PubTator, text mining | PubMed |
| H3K27 acetylation activated-PDLIM7 promotes castration-resistant prostate cancer progression by inducing O-Glycosylation of YAP1 protein. | Transl Oncol | 2024 | 38056280 | PubTator, text mining | PubMed |
| Silencing of PD-1 combined with EBV-specific killer T cells for the treatment of EBV-associated B lymphoma. | Transl Oncol | 2024 | 38039947 | PubTator, text mining | PubMed |
| Employing Noble Metal-Porphyrins to Engineer Robust and Highly Active Single-Atom Nanozymes for Targeted Catalytic Therapy in Nasopharyngeal Carcinoma. | Adv Mater | 2024 | 37994246 | PubTator, text mining | PubMed |
| Vault RNAs (vtRNAs): Rediscovered non-coding RNAs with diverse physiological and pathological activities. | Genes Dis | 2024 | 37692527 | PubTator, text mining | PubMed |
| γδ T cells: Major advances in basic and clinical research in tumor immunotherapy. | Chin Med J (Engl) | 2024 | 37592858 | PubTator, text mining | PubMed |
| The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer. | Curr Cancer Drug Targets | 2024 | 37183458 | PubTator, text mining | PubMed |
| Simultaneous proteome localization and turnover analysis reveals spatiotemporal features of protein homeostasis disruptions. | bioRxiv | 2024 | 36711879 | PubTator, text mining | PubMed |
| EBV-microRNAs as Potential Biomarkers in EBV-related Fever: A Narrative Review. | Curr Mol Med | 2024 | 36411555 | PubTator, text mining | PubMed |
| Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma. | Microorganisms | 2023 | 38276183 | PubTator, text mining | PubMed |
| Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation. | Front Immunol | 2023 | 38274824 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=9